Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05825209Phase 3Completed
Phase 3, randomised, double-blind trial (2 arms), sponsored by RDC Clinical. Primary endpoints: Change in sleep quality via Consensus Sleep Diary - Morning Administration at week 8 and Change in sleep quantity via Consensus Sleep Diary - Morning Administration at week 8. Started Apr 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05825209.